Svensson KA[au] - Search Results

Year	Number of Results
1994	2
1996	1
1997	2
1998	4
1999	1
2001	6
2002	1
2003	1
2005	1
2006	4
2008	3
2009	2
2010	2
2011	3
2012	4
2013	2
2015	2
2016	2
2017	2
2018	3
2019	3
2020	2
2021	5
2022	5
2023	1

1

Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs.

Bradley SJ, Molloy C, Valuskova P, Dwomoh L, Scarpa M, Rossi M, Finlayson L, Svensson KA, Chernet E, Barth VN, Gherbi K, Sykes DA, Wilson CA, Mistry R, Sexton PM, Christopoulos A, Mogg AJ, Rosethorne EM, Sakata S, John Challiss RA, Broad LM, Tobin AB. Bradley SJ, et al. Among authors: svensson ka. Nat Chem Biol. 2020 Mar;16(3):240-249. doi: 10.1038/s41589-019-0453-9. Epub 2020 Feb 20. Nat Chem Biol. 2020. PMID: 32080630 Free article.

2

Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia.

Fell MJ, McKinzie DL, Monn JA, Svensson KA. Fell MJ, et al. Among authors: svensson ka. Neuropharmacology. 2012 Mar;62(3):1473-83. doi: 10.1016/j.neuropharm.2011.06.007. Epub 2011 Jun 21. Neuropharmacology. 2012. PMID: 21704048 Review.

3

Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders.

Svensson KA, Hao J, Bruns RF. Svensson KA, et al. Adv Pharmacol. 2019;86:273-305. doi: 10.1016/bs.apha.2019.06.001. Epub 2019 Jul 13. Adv Pharmacol. 2019. PMID: 31378255 Review.

4

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial.

Biglan K, Munsie L, Svensson KA, Ardayfio P, Pugh M, Sims J, Brys M. Biglan K, et al. Among authors: svensson ka. Mov Disord. 2022 Mar;37(3):513-524. doi: 10.1002/mds.28879. Epub 2021 Dec 2. Mov Disord. 2022. PMID: 34859493 Free PMC article. Clinical Trial.

5

Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.

Yang CR, Svensson KA. Yang CR, et al. Among authors: svensson ka. Pharmacol Ther. 2008 Dec;120(3):317-32. doi: 10.1016/j.pharmthera.2008.08.004. Epub 2008 Aug 27. Pharmacol Ther. 2008. PMID: 18805436 Review.

6

Synthesis and Preclinical Characterization of LY3154885, a Human Dopamine D1 Receptor Positive Allosteric Modulator with an Improved Nonclinical Drug-Drug Interaction Risk Profile.

Hao J, Beck J, Zhou X, Lackner GL, Johnston R, Reinhard M, Goldsmith P, Hollinshead S, Dehlinger V, Filla SA, Wang XS, Richardson J, Posada M, Mohutsky M, Schober D, Katner JS, Chen Q, Hu B, Remick DM, Coates DA, Mathes BM, Hawk MK, Svensson KA, Hembre E. Hao J, et al. Among authors: svensson ka. J Med Chem. 2022 Mar 10;65(5):3786-3797. doi: 10.1021/acs.jmedchem.1c01887. Epub 2022 Feb 17. J Med Chem. 2022. PMID: 35175768

7

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator, in Patients With Parkinson Disease.

Wilbraham D, Biglan KM, Svensson KA, Tsai M, Pugh M, Ardayfio P, Kielbasa W. Wilbraham D, et al. Among authors: svensson ka. Clin Pharmacol Drug Dev. 2022 Mar;11(3):324-332. doi: 10.1002/cpdd.1039. Epub 2021 Oct 19. Clin Pharmacol Drug Dev. 2022. PMID: 34664427 Free PMC article.

8

Usability and inter-rater reliability of the NeuroMotion app: A tool in General Movements Assessments.

Svensson KA, Örtqvist M, Bos AF, Eliasson AC, Sundelin HE. Svensson KA, et al. Eur J Paediatr Neurol. 2021 Jul;33:29-35. doi: 10.1016/j.ejpn.2021.05.006. Epub 2021 May 18. Eur J Paediatr Neurol. 2021. PMID: 34052727 Free article.

9

Ensemble Docking Approach to Mitigate Pregnane X Receptor-Mediated CYP3A4 Induction Risk.

Chen Q, Zhou X, Rehmel J, Steele JP, Svensson KA, Beck JP, Hembre EJ, Hao J. Chen Q, et al. Among authors: svensson ka. J Chem Inf Model. 2023 Jan 9;63(1):173-186. doi: 10.1021/acs.jcim.2c01175. Epub 2022 Dec 6. J Chem Inf Model. 2023. PMID: 36473234

10

The Dopamine D1 Receptor Positive Allosteric Modulator Mevidalen (LY3154207) Enhances Wakefulness in the Humanized D1 Mouse and in Sleep-Deprived Healthy Male Volunteers.

McCarthy AP, Svensson KA, Shanks E, Brittain C, Eastwood BJ, Kielbasa W, Biglan KM, Wafford KA. McCarthy AP, et al. Among authors: svensson ka. J Pharmacol Exp Ther. 2022 Mar;380(3):143-152. doi: 10.1124/jpet.121.000719. Epub 2021 Dec 10. J Pharmacol Exp Ther. 2022. PMID: 34893551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results